Viewing StudyNCT00143455



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00143455
Status: COMPLETED
Last Update Posted: 2010-02-18
First Post: 2005-09-01

Brief Title: Study Of Irinotecan Hydrochloride CamptoR And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer
Sponsor: Pfizer
Organization: Pfizer

Organization Data

Organization: Pfizer
Class: INDUSTRY
Study ID: XRP4174D-3001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Director Clinical Trial Disclosure Group
Old Organization: Pfizer Inc

Collaborators